首页|不同剂量新活素在急诊PCI治疗急性心肌梗死中的效果与安全性

不同剂量新活素在急诊PCI治疗急性心肌梗死中的效果与安全性

扫码查看
目的 分析不同剂量新活素在急诊经皮冠状动脉介入(PCI)治疗急性心肌梗死中的效果与安全性.方法 64例急性心肌梗死患者随机分为两组.在急诊PCI治疗期间,A组给予0.01 µg·kg-1·min-1新活素,B组给予0.015µg·kg-·min-1新活素,持续给药24 h.比较两组的治疗效果、血管内皮功能以及不良反应.结果 两组的治疗总有效率、不良反应发生率比较,差异无统计学意义(P>0.05).治疗后,B组的ET-1明显低于A组,NO明显高于A组(P<0.05).结论 大剂量新活素可明显改善急诊PCI治疗的急性心肌梗死患者的临床症状,提升其血管内皮功能,且不会增加用药风险.
Effects and Safety of Different Doses of rhBNP in Emergency PCI for the Treatment of Acute Myocardial Infarction
Objective To analyze the effects and safety of different doses of rhBNP in emergency percutaneous coronary intervention(PCI)for the treatment of acute myocardial infarction.Methods 64 patients with acute myocardial infarction were randomly divided into two groups.During emergency PCI treatment,group A was given 0.01 µg·kg-1·min-1 rhBNP,and group B was given 0.015 μg·kg-1·min-1 rhBNP for 24 h continuously.The therapeutic effect,vascular endothelial function and adverse reactions were compared between the two groups.Results No significant difference was found in the total effective rate and incidence of adverse reactions between the two groups(P>0.05).After treatment,ET-1 in group B was significantly lower than that in group A,and NO was significantly higher than that in group A(P<0.05).Conclusions High-dose rhBNP can obviously improve the clinical symptoms of patients with acute myocardial infarction treated by emergency PCI,and improve their vascular endothelial function,without increase of medication risk.

rhBNPEmergency PCIAcute myocardial infarctionVascular endothelial functionEfficacySafety

刘钰、卢士建、王琛

展开 >

信阳市中心医院急诊内科,河南信阳 464000

信阳市中心医院心内科,河南信阳 464000

新活素 急诊PCI 急性心肌梗死 血管内皮功能 疗效 安全性

2024

临床医学工程
国家医疗保健器具工程技术研究中心

临床医学工程

影响因子:0.193
ISSN:1674-4659
年,卷(期):2024.31(10)